Overview

Definition:
-A marginal ulcer is a late complication of gastric bypass surgery, occurring at the gastrojejunal anastomosis or the gastric pouch remnant
-It is characterized by a full-thickness defect in the mucosa and submucosa of the gastrointestinal tract at the surgical connection.
Epidemiology:
-The incidence of marginal ulcers after gastric bypass ranges from 0.6% to 17%, with some studies reporting higher rates
-Risk factors include NSAID use, H
-pylori infection, smoking, and stricture at the anastomosis
-It typically presents between 6 months and 2 years post-operatively, but can occur earlier or later.
Clinical Significance:
-Marginal ulcers can lead to significant morbidity, including bleeding, perforation, and obstruction, requiring urgent surgical intervention and impacting patient recovery and long-term outcomes
-Accurate diagnosis and timely management are crucial for preventing life-threatening complications.

Clinical Presentation

Symptoms:
-Epigastric pain, often burning or gnawing, that may be similar to pre-operative dyspepsia or related to food intake
-Nausea and vomiting, especially after consuming solids
-Early satiety
-Bleeding, presenting as hematemesis or melena
-Perforation, with sudden severe abdominal pain, rigidity, and signs of peritonitis
-Obstruction, causing persistent vomiting and inability to tolerate oral intake.
Signs:
-Tenderness in the epigastric region
-Signs of anemia if bleeding is present (pallor, tachycardia)
-Signs of peritonitis (rebound tenderness, guarding) if perforation has occurred
-Distended abdomen and high-pitched bowel sounds if obstruction is present
-Vital sign abnormalities may include tachycardia and hypotension in cases of significant bleeding or perforation.
Diagnostic Criteria:
-Diagnosis is primarily based on clinical suspicion confirmed by upper gastrointestinal endoscopy
-Endoscopic findings include erythema, erosions, and discrete ulcerations at the gastrojejunal anastomosis
-Biopsies are taken to rule out malignancy and test for H
-pylori
-Radiographic evidence (e.g., contrast studies) may suggest but are not definitive for ulceration.

Diagnostic Approach

History Taking:
-Detailed history of bariatric surgery type and date
-Review of post-operative course, including any previous complications
-Assessment of pain characteristics, timing, and relation to meals
-Inquiry about NSAID use, smoking, and alcohol consumption
-History of H
-pylori infection
-Assessment for signs of bleeding (melena, hematemesis) or obstruction (vomiting).
Physical Examination:
-Thorough abdominal examination, assessing for tenderness, guarding, rebound tenderness, masses, and signs of distension
-Examination for pallor and other signs of anemia
-Evaluation of vital signs for hemodynamic stability.
Investigations:
-Complete blood count (CBC) to assess for anemia and infection
-Liver function tests (LFTs)
-Renal function tests (RFTs)
-Upper gastrointestinal endoscopy with biopsy for H
-pylori testing and to rule out malignancy
-Barium swallow or CT scan may be used to assess for complications like stricture or perforation, especially if endoscopy is not immediately available or conclusive.
Differential Diagnosis:
-Peptic ulcer disease (non-anastomotic)
-Gastritis
-GERD
-Gastric stasis
-Marginal zone lymphoma
-Anastomotic stricture without ulcer
-Bile reflux gastritis.

Management

Initial Management:
-Discontinuation of NSAIDs and offending agents
-Aggressive proton pump inhibitor (PPI) therapy, typically intravenous initially
-Nasogastric tube decompression if obstruction is suspected
-Fluid resuscitation and correction of electrolyte imbalances
-Blood transfusion if significant bleeding is present.
Medical Management:
-High-dose PPI therapy (e.g., pantoprazole 40 mg IV twice daily, transitioning to oral)
-Eradication therapy for H
-pylori if positive, using a combination of PPI, bismuth, and two antibiotics (e.g., clarithromycin, amoxicillin, metronidazole) for 10-14 days
-Sucralfate can be used as an adjunct
-Smoking cessation counseling.
Surgical Management:
-Surgical intervention is indicated for refractory ulcers, bleeding, perforation, or obstruction
-Options include: Revision of anastomosis with ulcer excision and resuturing
-Conversion to Roux-en-Y gastrojejunostomy if a loop bypass was performed
-Resection of gastric pouch if the ulcer is in the remnant
-In cases of perforation, emergency laparotomy with repair and possible pouch revision
-Laparoscopic techniques are preferred when feasible, but conversion to open surgery may be necessary.
Supportive Care:
-Nutritional support, including parenteral or enteral feeding if oral intake is compromised
-Close monitoring of vital signs, pain, and output
-Regular laboratory monitoring for anemia and electrolytes
-Pain management
-Education regarding lifestyle modifications.

Complications

Early Complications: Hemorrhage, perforation, acute gastric outlet obstruction, anastomotic leak.
Late Complications:
-Chronic pain, stricture formation, internal herniation (rarely related directly to ulcer but co-existing), malnutrition, vitamin deficiencies
-Recurrence of ulceration.
Prevention Strategies:
-Meticulous surgical technique to create a tension-free anastomosis
-Avoidance of NSAIDs and smoking
-Screening and eradication of H
-pylori pre-operatively
-Liberal use of PPIs post-operatively, especially in high-risk patients
-Patient education on lifestyle modifications and medication adherence.

Prognosis

Factors Affecting Prognosis:
-Promptness of diagnosis and initiation of treatment
-Severity of ulceration and presence of complications (bleeding, perforation, obstruction)
-Patient comorbidities
-Adherence to medical and lifestyle recommendations
-Successful surgical revision if indicated.
Outcomes:
-With appropriate medical and surgical management, most marginal ulcers can be healed
-However, recurrence is possible
-Outcomes are generally good for uncomplicated ulcers treated medically
-Complicated ulcers requiring surgery have higher morbidity and longer recovery periods.
Follow Up:
-Long-term follow-up with a bariatric surgery team is essential
-Regular endoscopic surveillance may be recommended, particularly for patients with a history of ulcers or ongoing risk factors
-Continued PPI use may be necessary for some patients
-Dietary and lifestyle counseling.

Key Points

Exam Focus:
-Marginal ulcers occur at the gastrojejunal anastomosis post-GBP
-Key symptoms mimic pre-op dyspepsia but can include bleeding or obstruction
-Diagnosis is by endoscopy
-Management involves PPIs, H
-pylori eradication, and surgical revision for refractory/complicated cases
-NSAIDs and smoking are major risk factors.
Clinical Pearls:
-Always consider marginal ulcer in patients with post-GBP epigastric pain or new-onset dyspepsia
-Endoscopy is the gold standard
-Early surgical intervention for perforation or severe bleeding is life-saving
-Lifestyle modification is critical for prevention and management.
Common Mistakes:
-Attributing all post-GBP epigastric pain to "dumping syndrome" without considering marginal ulcer
-Delaying endoscopy in patients with concerning symptoms
-Inadequate PPI dosage or duration
-Failure to screen for and eradicate H
-pylori
-Ignoring the role of NSAIDs and smoking.